We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $21.7B
1-Year Est. Return 30.58%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+30.58%
3 Year Est. Return
+82.67%
5 Year Est. Return
+103.42%
10 Year Est. Return
+340.42%
AUM
$6.71B
AUM Growth
+$133M
Cap. Flow
+$178M
Cap. Flow %
2.66%
Top 10 Hldgs %
26.7%
Holding
442
New
38
Increased
200
Reduced
128
Closed
18

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$44.9M
2
HSY icon
Hershey
HSY
+$33.9M
3
VTR icon
Ventas
VTR
+$33.1M
4
PAYX icon
Paychex
PAYX
+$31M
5
PEP icon
PepsiCo
PEP
+$26.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$54.8M
2
AAPL icon
Apple
AAPL
+$24M
3
O icon
Realty Income
O
+$21.6M
4
CFR icon
Cullen/Frost Bankers
CFR
+$17.6M
5
IBM icon
IBM
IBM
+$8.55M

Sector Composition

Rank Sector Weight
1 Healthcare 16.32%
2 Technology 16.19%
3 Consumer Staples 15.5%
4 Industrials 11.78%
5 Energy 11.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$334B
$337M 5.02%
4,022,164
-7,778
-0.2% -$637K
JNJ icon
2
Johnson & Johnson
JNJ
$646B
$222M 3.31%
2,081,738
+36,173
+2% +$3.75M
MSFT icon
3
Microsoft
MSFT
$3.81T
$183M 2.73%
3,957,389
+196,970
+5% +$8.79M
USB icon
4
US Bancorp
USB
$97.3B
$182M 2.71%
4,349,821
+60,367
+1% +$2.55M
CVX icon
5
Chevron
CVX
$396B
$157M 2.34%
1,317,553
+45,667
+4% +$5.83M
NVS icon
6
Novartis
NVS
$292B
$156M 2.32%
1,848,419
+25,194
+1% +$2.04M
GE icon
7
GE Aerospace
GE
$355B
$144M 2.15%
1,173,420
+47,731
+4% +$5.95M
EMR icon
8
Emerson Electric
EMR
$86.6B
$140M 2.09%
2,237,753
+48,474
+2% +$3.15M
KO icon
9
Coca-Cola
KO
$386B
$139M 2.07%
3,251,954
+50,764
+2% +$2.1M
QCOM icon
10
Qualcomm
QCOM
$175B
$131M 1.96%
1,756,283
+39,812
+2% +$3.05M
WMB icon
11
Williams Companies
WMB
$90.2B
$130M 1.94%
2,353,866
-109,760
-4% -$6.31M
CSCO icon
12
Cisco
CSCO
$433B
$129M 1.92%
5,124,941
+128,908
+3% +$3.24M
OKE icon
13
Oneok
OKE
$59.7B
$129M 1.92%
1,961,140
-28,455
-1% -$1.91M
ABBV icon
14
AbbVie
ABBV
$451B
$128M 1.91%
2,213,278
+67,703
+3% +$3.76M
MCD icon
15
McDonald's
MCD
$188B
$122M 1.82%
1,288,879
+10,268
+0.8% +$979K
MRK icon
16
Merck
MRK
$366B
$122M 1.81%
2,150,886
+79,269
+4% +$4.45M
BLK icon
17
Blackrock
BLK
$180B
$115M 1.72%
351,075
+10,921
+3% +$3.51M
MMM icon
18
3M
MMM
$89.9B
$112M 1.67%
944,683
+373,305
+65% +$44.9M
LYB icon
19
LyondellBasell Industries
LYB
$20.6B
$104M 1.55%
956,579
+53,182
+6% +$5.75M
KMB icon
20
Kimberly-Clark
KMB
$36.4B
$98.9M 1.47%
959,297
+32,387
+3% +$3.37M
INTC icon
21
Intel
INTC
$473B
$96.5M 1.44%
2,772,330
-70,866
-2% -$2.4M
BAX icon
22
Baxter International
BAX
$13.5B
$94.7M 1.41%
2,429,384
+200,920
+9% +$8.16M
LMT icon
23
Lockheed Martin
LMT
$130B
$93.2M 1.39%
509,801
+17,149
+3% +$2.92M
SE
24
DELISTED
Spectra Energy Corp Wi
SE
$90.3M 1.35%
2,299,783
+97,981
+4% +$4.03M
KRFT
25
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$90.1M 1.34%
1,597,955
+56,667
+4% +$3.28M

Similar funds

Bahl & Gaynor's Q3 2014 Portfolio in Review

As of Q3 2014, Bahl & Gaynor held 442 positions worth $6.71B, up 2% from $6.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q3 2014 filing shows 38 new, 200 increased, 128 reduced and 18 closed positions. Its largest new stake was Cracker Barrel: 9,775 shares worth $1.01M. The largest sale was GSK, an estimated $54.8M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Staples.

  • Bahl & Gaynor's largest Q3 2014 buy was Cracker Barrel: 9,775 shares worth $1.01M.
  • Bahl & Gaynor added most to 3M in Q3 2014, an estimated $44.9M increase.
  • Bahl & Gaynor's biggest Q3 2014 reduction was GSK, cutting an estimated $54.8M.
  • Bahl & Gaynor fully exited GNC Holdings, Inc. in Q3 2014, selling an estimated $2.07M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.71B portfolio in Q3 2014.
  • Bahl & Gaynor opened 38 new positions and closed 18 in Q3 2014.
  • Bahl & Gaynor's portfolio value rose 2% quarter-over-quarter to $6.71B.

Based on Bahl & Gaynor's 13F filing for Q3 2014, filed 12 Nov 2014.